- Companies
- Welle
Welle Valuation, Funding & Investors
Welle is valued at $1.2B as of January 2024.
Last Welle valuation
$1.2B
Pre-seed · Jan 2024
Last Welle funding round
$2M
Pre-seed · Jan 2024
Cumulative funding Welle raised
$2M
across 1 funding round
Welle Overview
About Welle
Welle is a digital health company based in New York providing personalized care plans to mitigate inflammation and chronic disease risks. Its platform uses at-home testing kits for biomarkers like hsCRP and offers nutrition, supplement, and lifestyle recommendations via app-based coaching. Welle targets corporate wellness programs and partners with employers in finance and tech sectors for employee health initiatives.
Founded
2023
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription, Product sales
Valuation
$1.2B (Jan 2024)
Welle Valuation
Welle is currently valued at $1.2B, based on its pre-seed round in January 2024.
Welle valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Jan 2024 | Pre-seed | $1.2B |
Welle Funding History
Welle has raised a total of $2M across 1 funding round.
Welle funding rounds
| Date | Stage | Raised | Valuation |
|---|---|---|---|
| Jan 2024 | Pre-seed | $2M | $1.2B |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialWelle Competitors
Welle competitors include listed companies like DarioHealth and Certara, and private ones like Twin Health, Evidation Health, Cult.fit and Glooko.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.4B | - | ||
| Private | - | - | $1B | - | ||
| Private | $74M | - | $1.5B | - | ||
| Private | - | - | $476M | - | ||
| Publicly listed | $22M | ($36M) | $69M | 4.0x | ||
| Publicly listed | $419M | $103M | $1.3B | 3.6x |
Welle Public Comps
Welle is still privately-owned, but its public comps include Omada Health, Certara, Helus Pharma, Nutex Health, Indegene, JMDC, Sphere, SOPHiA Genetics, Dian Diagnostics Group and Alignment Healthcare.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $260M | ($10M) | 3.8x | 3.1x | (98.6x) | 48.5x | |||
| $419M | $103M | 3.4x | 3.6x | 13.9x | 12.0x | |||
| - | ($153M) | - | - | (5.4x) | (4.8x) | |||
| $875M | $288M | 2.0x | 2.0x | 6.0x | 6.4x | |||
| $366M | $68M | 3.7x | 3.3x | 19.9x | 18.2x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $70M | $6M | 14.3x | 6.9x | 156.3x | 103.0x | |||
| $77M | ($65M) | 8.8x | 7.5x | (10.4x) | (18.8x) | |||
This data is available for Pro users. Sign up to see all Welle competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Welle
| When was Welle founded? | Welle was founded in 2023. |
| Where is Welle headquartered? | Welle is headquartered in Los Angeles, CA, United States. |
| Is Welle publicly listed? | No, Welle is a private company. |
| What is Welle's valuation? | Welle was last valued at $1.2B in its pre-seed round in January 2024. |
| How much funding has Welle raised? | Welle has raised $2M across 1 funding round. |
| What was Welle's last funding round? | Welle's last funding round was a $2M pre-seed round in January 2024. |
| Which companies are comparable to Welle? | Companies comparable to Welle include Twin Health, Evidation Health, Cult.fit, Glooko, DarioHealth and Certara. |
See companies similar to Welle
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




